Company: SXTPW
Filing Date: 2025-01-30
Form Type: 424B5
Source: 0001213900-25-008098
Chunk: 32

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-30
Form: 424B5
Chunk 32
---
69.96 per share;    |

| ● | 31,300                                                                                             
 shares of common stock issuable upon exercise of the representative warrants to the representative 
 in our public offering at an exercise price of $5.082 per share;                                   |

| ● | 217,391                                                                                                                                  
 shares of common stock issuable upon exercise of the representative warrants to the representative in our public offering at an exercise 
 price of $1.725 per share;                                                                                                               |

| ● | shares                                                                                     
 of common stock issuable upon the conversion of 76,480 shares of Series A Preferred Stock; |

| ● | 1,666,670                                                                                 
 shares of common stock issuable upon the exercise of the Private Placement Warrants to be 
 issued in the concurrent private placement at an exercise price of $0.771 per share; and  |

| ● | 76,616                                                                                     
 shares of common stock issuable upon the exercise of placement agent warrants to be issued 
 as compensation to the placement agent (or its designee) in connection with this offering  
 at an exercise price of $1.2763 per share.                                                 |

| (2) | Unless                                                                                          
 otherwise indicated, this prospectus supplement reflects and assumes no exercise of the options 
 and warrants described above.                                                                   |

<div align='center'>S-19

RISK FACTORS</div>

Investing in our shares of common stock involves a high degree of risk. You should carefully consider the risks listed below and other information included and incorporated by reference in this prospectus supplement and accompanying prospectus. There may also be risks of which we are currently unaware, or that we currently regard as immaterial based on the information available to us that later prove to be material. If any of these risks occur, our business, operating results and financial condition could be seriously harmed, the trading price of our common stock could decline, and you could lose some or all of your investment.

Risks Related to this Offering and Ownership of our Securities

Future sales by stockholders, or the perception that such sales may occur, may depress the price of our common stock.

The sale or availability for sale of substantial amounts of our shares in the public market or exercise of common stock warrants and options or settlement of restricted stock units, or the perception that such sales could occur, could adversely affect the market price of our common stock and also could impair our ability to raise capital through future offerings of our shares. As of January 28, 2025, we had 4,395